GlobeImmune
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income.

Profit Margin

GlobeImmune, Inc. (OTC:GBIM): Profit margin
2012 14.64M -2.01M -13.76%
2013 22.51M 9.47M 42.08%
2014 5.96M -20.15M -337.75%
2015 6.45M -2.76M -42.85%
2019 0 0
2020 0 0
2021 0 0
2022 0 0

GBIM Income Statement (2012 – 2022)

2022 2021 2020 2019 2015 2014 2013 2012
Revenue
Revenue
00006.45M5.96M22.51M14.64M
Cost of revenue
00002.64M4.99M00
Gross profit
00003.80M974.16K22.51M14.64M
Operating exp.
Research and development
00004.48M7.21M10.88M11.73M
Selling and marketing
00000000
Total operating expenses
00009.22M11.78M14.83M18.60M
Operating income
0000-2.76M-5.81M7.68M-3.96M
Other income (expenses), net
00000-10.44M1.90M1.95M
Income before tax
0000-2.76M-16.26M9.59M-2.01M
Income tax expense
0000199.99K3.89M115.76K0
Net income
0000-2.76M-20.15M9.47M-2.01M
Earnings per share
Basic EPS
0000-0.48-6.91-35.64-21.06
Diluted EPS
0000-0.48-6.91-35.64-21.06